charmed, nerf,,re: management
JP and GTCB's Cox make a good comparison,,,both know their stuff,,,JP still has to prove himself to Wall St.,,but Cox has diluted shareholder value by a factor of 10 compared to RPRX,,,,regardless of the science, that should have made follow his own rule 101,,,run like hell.
In that regard, JP is head and shoulders a better CEO over Cox and JP still has four months to find that Japanese Pharma partner based on his official statement in Dec/07.
jmo